Omega 3 Fatty Acids & anticoagulants
Our assessment
Based on the provided FDA data, the overall safety profile for this supplement shows a critical interaction with anticoagulants. The data indicates that concurrent use may increase the risk of bleeding events. Patients taking blood thinners should exercise caution. FDA FAERS ↗
Safety profile
Specific adverse event report counts are not available in the provided data. The primary safety concern identified is the drug interaction with anticoagulants. No other side effects or report numbers are listed in the supplied information. FDA FAERS ↗
How it works
The exact mechanism of action is not detailed in the provided data. The key finding is a potential interaction with anticoagulant medications, which may alter their effectiveness and increase bleeding risk. FDA FAERS ↗
Our recommendation
Patients currently taking anticoagulants should consult their healthcare provider before using this supplement. Data on dose thresholds, specific populations, and other drug interactions is not available. FDA FAERS ↗
AI-assisted analysis. Data sourced from NIH ODS.
Omega-3 Fatty Acids may interact with anticoagulants. Omega-3 dietary supplements may interact with the medications you take. For example, high doses of omega-3s may cause bleeding problems when taken with warfarin (Coumadin) or other anticoagulant medicines. Talk with your health care provider about possible interactions between omega-3 supplements and your medications.
Safe Alternatives
These supplements have no known interaction with anticoagulants: